This Review discusses cholangiocarcinoma, the incidence of which is increasing globally. There are several established risk factors for cholangiocarcinoma, and others are now being recognized. Diagnosis requires the integration of clinical information, imaging studies, tumor markers and histology. Surgery can be curative, but most patients have unresectable disease, in which case palliation can improve quality of life and might also improve survival.
